These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 623854)

  • 1. Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder.
    Barkai AI; Dunner DL; Gross HA; Mayo P; Fieve RR
    Biol Psychiatry; 1978 Feb; 13(1):65-72. PubMed ID: 623854
    [No Abstract]   [Full Text] [Related]  

  • 2. Amino acid concentrations in cerebrospinal fluid: effects of aging, depression, and probenecid.
    Goodnick PJ; Evans HE; Dunner DL; Fieve RR
    Biol Psychiatry; 1980 Aug; 15(4):557-63. PubMed ID: 7397286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF AMP in primary affective disorder: effects of probenecid and tryptophan.
    Goodnick PJ; Perel JM; Dunner DL; Fieve RR
    Biol Psychiatry; 1980 Feb; 15(1):173-6. PubMed ID: 6244008
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclic AMP in cerebrospinal fluid of manic and depressive patients.
    Post RM; Cramer H; Goodwin FK
    Psychol Med; 1977 Nov; 7(4):599-605. PubMed ID: 201957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid norepinephrine in affective illness.
    Post RM; Lake CR; Jimerson DC; Bunney WE; Wood JH; Ziegler MG; Goodwin FK
    Am J Psychiatry; 1978 Aug; 135(8):907-12. PubMed ID: 665831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.
    Port JD; Unal SS; Mrazek DA; Marcus SM
    Psychiatry Res; 2008 Feb; 162(2):113-21. PubMed ID: 18164911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings.
    Silverstone PH; McGrath BM; Kim H
    Bipolar Disord; 2005 Feb; 7(1):1-10. PubMed ID: 15654927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients.
    Regenold WT; Hisley KC; Obuchowski A; Lefkowitz DM; Marano C; Hauser P
    J Affect Disord; 2005 Apr; 85(3):341-50. PubMed ID: 15780705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patients.
    Lerner P; Goodwin FK; van Kammen DP; Post RM; Major LF; Ballenger JC; Lovenberg W
    Biol Psychiatry; 1978 Dec; 13(6):685-94. PubMed ID: 737256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An examination of baseline and drug-induced levels of cyclic nucleotides in the cerebrospinal fluid of control and psychiatric patients.
    Smith CC; Tallman JF; Post RM; van Kammen DP; Jimerson DC; Brown GL
    Life Sci; 1976 Jul; 19(1):131-6. PubMed ID: 940431
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis of manic-depressive psychosis from cerebrospinal fluid concentration of 5-hydroxyindoleacetic acid.
    Sjöström R
    Adv Biochem Psychopharmacol; 1974; 11(0):369-75. PubMed ID: 4845705
    [No Abstract]   [Full Text] [Related]  

  • 12. Cortisol in the cerebrospinal fluid of patients suffering from affective disorders.
    Coppen A; Brooksbank BW; Noguera R; Wilson DA
    J Neurol Neurosurg Psychiatry; 1971 Aug; 34(4):432-5. PubMed ID: 5096556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid.
    van Praag HM; Korf J; Puite J
    Nature; 1970 Mar; 225(5239):1259-60. PubMed ID: 5435360
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluorometric measurement of 5-hydroxyindoleacetic acid (5HIAA) and tryptophan in human CSF: effects of high doses of probenecid.
    Bowers MB
    Biol Psychiatry; 1974 Aug; 9(1):93-8. PubMed ID: 4457119
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebrospinal fluid amine metabolites in affective illness and schizophrenia: clinical and pharmacological studies.
    Goodwin FK; Post RM
    Psychopharmacol Commun; 1975; 1(6):641-53. PubMed ID: 1224017
    [No Abstract]   [Full Text] [Related]  

  • 16. Central norepinephrine metabolism in affective illness: MHPG in the cerebrospinal fluid.
    Post RM; Gordon EK; Goodwin FK; Bunney WE
    Science; 1973 Mar; 179(4077):1002-3. PubMed ID: 4687583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated myo-inositol concentrations in cerebrospinal fluid of neonates and of patients with an impaired state of consciousness.
    Lepkifker E; Lewin LM
    Biomedicine; 1976 Dec; 25(10):368-71. PubMed ID: 1016679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin F in patients with primary affective disorder.
    Gross HA; Dunner DL; Lafleur D; Meltzer HL; Fieve RR
    Biol Psychiatry; 1977 Jun; 12(3):347-57. PubMed ID: 871488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inositol augmentation of lithium or valproate for bipolar depression.
    Eden Evins A; Demopulos C; Yovel I; Culhane M; Ogutha J; Grandin LD; Nierenberg AA; Sachs GS
    Bipolar Disord; 2006 Apr; 8(2):168-74. PubMed ID: 16542187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.
    Lan MJ; McLoughlin GA; Griffin JL; Tsang TM; Huang JT; Yuan P; Manji H; Holmes E; Bahn S
    Mol Psychiatry; 2009 Mar; 14(3):269-79. PubMed ID: 18256615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.